Godsey & Gibb Inc’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $18.7K | Hold |
778
| – | – | ﹤0.01% | 243 |
|
|
2026
Q1 | $21.9K | Sell |
778
-33
| -4% | -$879 | ﹤0.01% | 227 |
|
|
2025
Q4 | $20.2K | Sell |
811
-3,717
| -82% | -$93.7K | ﹤0.01% | 239 |
|
|
2025
Q3 | $115K | Buy |
4,528
+3,569
| +372% | +$88.1K | 0.01% | 134 |
|
|
2025
Q2 | $23.3K | Hold |
959
| – | – | ﹤0.01% | 206 |
|
|
2025
Q1 | $24.3K | Hold |
959
| – | – | ﹤0.01% | 218 |
|
|
2024
Q4 | $25.4K | Sell |
959
-53
| -5% | -$1.44K | ﹤0.01% | 209 |
|
|
2024
Q3 | $29.3K | Sell |
1,012
-1,151
| -53% | -$33.6K | ﹤0.01% | 221 |
|
|
2024
Q2 | $60.5K | Buy |
2,163
+817
| +61% | +$22.5K | 0.01% | 172 |
|
|
2024
Q1 | $37.4K | Sell |
1,346
-701
| -34% | -$19.5K | ﹤0.01% | 184 |
|
|
2023
Q4 | $58.9K | Buy |
2,047
+1,016
| +99% | +$30.7K | 0.01% | 148 |
|
|
2023
Q3 | $34.2K | Sell |
1,031
-1,067
| -51% | -$37.7K | ﹤0.01% | 182 |
|
|
2023
Q2 | $77K | Buy |
2,098
+120
| +6% | +$4.67K | 0.01% | 141 |
|
|
2023
Q1 | $80.7K | Buy |
+1,978
| New | +$85.4K | 0.01% | 139 |
|
|
2022
Q4 | – | Sell |
-2,428
| Closed | -$106K | – | 329 |
|
|
2022
Q3 | $106K | Buy |
+2,428
| New | +$118K | 0.08% | 18 |
|
|
2021
Q2 | – | Sell |
-5,731
| Closed | -$208K | – | 144 |
|
|
2021
Q1 | $208K | Sell |
5,731
-3,672
| -39% | -$130K | 0.03% | 97 |
|
|
2020
Q4 | $346K | Buy |
+9,403
| New | +$345K | 0.05% | 72 |
|
|
2020
Q1 | – | Sell |
-375,913
| Closed | -$14M | – | 94 |
|
|
2019
Q4 | $14M | Sell |
375,913
-1,302
| -0.3% | -$46.4K | 1.96% | 38 |
|
|
2019
Q3 | $12.9M | Sell |
377,215
-3,783
| -1% | -$138K | 1.96% | 37 |
|
|
2019
Q2 | $15.7M | Buy |
380,998
+4,716
| +1% | +$187K | 2.26% | 24 |
|
|
2019
Q1 | $15.2M | Buy |
376,282
+8,237
| +2% | +$330K | 2.3% | 21 |
|
|
2018
Q4 | $15.2M | Sell |
368,045
-4,045
| -1% | -$168K | 2.74% | 7 |
|
|
2018
Q3 | $15.6M | Buy |
372,090
+3,105
| +0.8% | +$120K | 2.48% | 12 |
|
|
2018
Q2 | $12.7M | Sell |
368,985
-50,975
| -12% | -$1.74M | 2.2% | 21 |
|
|
2018
Q1 | $14.1M | Buy |
419,960
+7,753
| +2% | +$267K | 2.49% | 18 |
|
|
2017
Q4 | $14.2M | Sell |
412,207
-12,812
| -3% | -$437K | 2.38% | 18 |
|
|
2017
Q3 | $14.4M | Sell |
425,019
-32,872
| -7% | -$1.06M | 2.46% | 15 |
|
|
2017
Q2 | $14.6M | Buy |
457,891
+20,638
| +5% | +$651K | 2.56% | 12 |
|
|
2017
Q1 | $14.2M | Sell |
437,253
-10,932
| -2% | -$345K | 2.58% | 16 |
|
|
2016
Q4 | $13.8M | Buy |
448,185
+1,599
| +0.4% | +$48.8K | 2.56% | 17 |
|
|
2016
Q3 | $14.3M | Buy |
446,586
+2,762
| +0.6% | +$92.4K | 2.57% | 10 |
|
|
2016
Q2 | $14.8M | Buy |
443,824
+2,178
| +0.5% | +$69.5K | 2.69% | 7 |
|
|
2016
Q1 | $12.4M | Buy |
441,646
+6,012
| +1% | +$172K | 2.4% | 17 |
|
|
2015
Q4 | $13.3M | Sell |
435,634
-4,003
| -0.9% | -$126K | 2.63% | 9 |
|
|
2015
Q3 | $13.1M | Sell |
439,637
-19,657
| -4% | -$630K | 2.69% | 3 |
|
|
2015
Q2 | $14.6M | Sell |
459,294
-2,732
| -0.6% | -$89K | 2.59% | 2 |
|
|
2015
Q1 | $15.3M | Sell |
462,026
-7,426
| -2% | -$236K | 2.74% | 2 |
|
|
2014
Q4 | $13.9M | Buy |
469,452
+14,026
| +3% | +$402K | 2.58% | 2 |
|
|
2014
Q3 | $12.8M | Buy |
455,426
+12,690
| +3% | +$356K | 2.41% | 9 |
|
|
2014
Q2 | $12.5M | Sell |
442,736
-4,962
| -1% | -$141K | 2.36% | 12 |
|
|
2014
Q1 | $13.6M | Buy |
447,698
+10,888
| +2% | +$325K | 2.75% | 4 |
|
|
2013
Q4 | $12.7M | Buy |
436,810
+5,310
| +1% | +$155K | 2.58% | 6 |
|
|
2013
Q3 | $11.8M | Sell |
431,500
-11,982
| -3% | -$326K | 2.6% | 5 |
|
|
2013
Q2 | $11.8M | Buy |
+443,482
| New | +$12.3M | 2.73% | 4 |
|
Other funds holding PFE
Godsey & Gibb Inc's PFE Position: Q2 2026 in Review
Godsey & Gibb Inc held its Pfizer (PFE) position steady in Q2 2026 at 778 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #243.
Godsey & Gibb Inc first reported a position in PFE in Q2 2013 and has held it in 44 quarters since. The position peaked at $15.7M in Q2 2019. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Godsey & Gibb Inc held 778 shares of Pfizer worth $18.7K as of Q2 2026.
- Godsey & Gibb Inc left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up ﹤0.01% of Godsey & Gibb Inc's portfolio in Q2 2026, its #243 holding.
- Godsey & Gibb Inc first reported a position in Pfizer in Q2 2013 and has held it in 44 quarters since.
- Godsey & Gibb Inc's Pfizer position peaked at $15.7M in Q2 2019.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Godsey & Gibb Inc's 13F filing for Q2 2026, filed 13 Jul 2026.